HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹533 Cr | ₹643 Cr | ₹590 Cr | ₹432 Cr | ₹379 Cr |
What is the latest Total Non-Current Liabilities ratio of HIKAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹533 Cr |
| Mar2024 | ₹643 Cr |
| Mar2023 | ₹590 Cr |
| Mar2022 | ₹432 Cr |
| Mar2021 | ₹379 Cr |
How is Total Non-Current Liabilities of HIKAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹533 Cr | -17.09 | |
| Mar2024 | ₹643 Cr | 8.90 | |
| Mar2023 | ₹590 Cr | 36.71 | |
| Mar2022 | ₹432 Cr | 13.96 | |
| Mar2021 | ₹379 Cr | - | |
Compare Total Non-Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,807.5 Cr | -3.9% | 14.7% | -32.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.9% |
14.7% |
-32.8% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses